Israeli start-up uses ultrasound waves to treat Parkinson’s

News

Author: Simge Eva DoganPublished: 9 May 2019

Prep: Cook: Serves:

INSIGHTEC, a medical start-up based in Israel, is using ultrasound waves to treat Parkinson’s symptoms.

The treatment, called Exablate Neuro, uses non-invasive technology to alleviate tremors by directing high-intensity ultrasound beams to the VIM nucleus – the part of the brain where tremors are thought to originate.

Using specialist software, the ultrasound waves can also be used to provide surgeons with real-time feedback of any temperature changes in the areas being targeted.

Xen Mendelsohn Aderka, VP of marketing at INSIGHTEC, said: “The technology is being used in over 50 medical centres around the world, with over 2,000 neuro-patients treated.”

Aderka added that as the treatment is non-invasive, there is no risk of infection and patients can enjoy a rapid recovery.

INSIGHTEC obtained US Food and Drug Administration (FDA) approvals for its technology in 2016 and 2018.

To read more on this topic click here.

Could a transplant lower the risk of Parkinson’s?

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Parkinson’s ruined my calligraphy career – but not my life

There is life after Parkinson’s, insists blogger Twitchy Woman

#UniteForParkinsons: the story so far

Highlights from #UniteForParkinsons 2017

Carers Week launches in UK

2015 campaign focuses on building ‘carer-friendly communities’

Smartphone test predicts development of Parkinson’s symptoms, study says

Researchers have created a smartphone test that may be able to predict the development of Parkinson’s symptoms. The study – carried out by researchers from the University of Oxford and funded by the Monument Trust Discovery Award from charity Parkinson’s UK – used the test to assess voice, balance, walking and reaction time in people living with Parkinson’s. The results indicated that the test may be able to predict development of Parkinson’s symptoms up to 18 months before they occur. Researchers hope this will allow healthcare professionals to tailor a more personalised approach to the treatment of Parkinson’s. Christine Lo, clinical research fellow at the University of Oxford’s Oxford Parkinson’s Disease Centre, said: “The main driver for this study was to improve clinical care by finding better ways of predicting how Parkinson’s is likely to progress over time on an individual basis, as its course can vary greatly from person to…

Take part in a global Parkinson’s carers survey

The European Parkinson’s Disease Association (EPDA) is inviting carers from within the Parkinson’s community to take part in a survey aiming to shine a light on the physical, financial and emotional difficulties they face. The research – supported by French healthcare devices company Air Liquide – will be used to inform future campaigns and create valuable tools to help carers and the wider Parkinson’s community. Russell Patten, the secretary general of the EPDA, said: “Carers are such an important part of the Parkinson’s community – they provide the firm foundations that support their loved ones who are physically living with the condition. “However, carers’ needs and quality of life are sadly, all too often, overlooked; this can lead to devastating and lasting effects on the individual and the wider society.” The survey is open until 6 September 2019, and is available in English, French, German Italian, Danish, Dutch, Portuguese, Slovenian…

Scottish university reveals multimillion-pound Parkinson’s research partnership

The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s. Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition. The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development. Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together. “This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Israeli start-up uses ultrasound waves to treat Parkinson’s

News

Author: Simge Eva DoganPublished: 9 May 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Parkinson’s ruined my calligraphy career – but not my life

Global update

#UniteForParkinsons: the story so far

Carers' Corner

Carers Week launches in UK

Smartphone test predicts development of Parkinson’s symptoms, study says

Take part in a global Parkinson’s carers survey

Scottish university reveals multimillion-pound Parkinson’s research partnership

{title}

Subscribe

Israeli start-up uses ultrasound waves to treat Parkinson’s

News

Author: Simge Eva DoganPublished: 9 May 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Parkinson’s ruined my calligraphy career – but not my life

Global update

#UniteForParkinsons: the story so far

Carers' Corner

Carers Week launches in UK

Smartphone test predicts development of Parkinson’s symptoms, study says

Take part in a global Parkinson’s carers survey

Scottish university reveals multimillion-pound Parkinson’s research partnership

{title}

Subscribe

Sign in